Kraft Hires A Pharmaceutical Company To Help It Develop Functional Foods February 18, 2009 “Kraft Foods Global Inc. is taking a novel approach by using Minneapolis-based Medisyn Technologies Inc., a drug discovery company, to find bioactive ingredients for food use…Medisyn was introduced to Kraft through its business development partner Destum Partners, Charlotte, N.C.”
Destum Partners Secures An Immunotherapeutic Partnership For Pevion Biotech Ltd.
Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration.
WORCESTER, MA, December 16, 2008 (GlobeNewswire) – Generex Biotechnology Corporation (NasdaqCM:GNBT, www.generex.com) and Pevion Biotech Ltd. (www.pevion.com) have signed an agreement to work together to develop next-generation vaccines and immunotherapeutic products.
Destum Partners Secures Partnership For Its Client Medisyn Technologies With Kraft Foods
Medisyn Technologies Collaborates With Kraft Foods to Drive Discovery of Effective Bioactive Ingredients Suitable for Food Use.
MINNEAPOLIS, MN, January 14, 2009 – “Medisyn Technologies, Inc., announced today a research and licensing collaboration with Kraft Foods Global Inc. to discover effective bioactive ingredients suitable for food use. The work, which began in December, 2008, utilizes Medisyn’s Forward Engineering technology platform to identify, analyze and optimize promising bioactive compounds. This technology accurately predicts how a compound will behave based on its structure, greatly streamlining the discovery and development process of food ingredients that can be used to provide healthier choices for consumers.”